Home › Asset managers › Compare 2025-2026 › American Century vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,248 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
American Century 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 66,352 | 54,212 | 1,394 | 10,746 | 97.5% | 91.7% |
| Board proposals | 56,616 | 45,411 | 1,270 | 9,935 | 97.3% | 91.2% |
| E&S shareholder proposals | 173 | 0 | 1 | 172 | 0.0% | 40.1% |
| Other items | 9,563 | 8,801 | 123 | 639 | 98.6% | 95.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
9,935 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | Brighthouse |
|---|---|---|---|---|---|---|
| BETA BIONICS, INC. | May 21, 2026 | To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 3 FOR, 1 ABSTAIN |
| BGC GROUP INC. | November 12, 2025 | Approval of the ratification of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for fiscal year 2025. Audit-related |
Board | For | FOR 2 funds |
Split 2 FOR, 2 ABSTAIN |
| BGC GROUP INC. | November 12, 2025 | Approval, on an advisory basis, of executive compensation. Say-on-Pay |
Board | For | AGAINST 3 funds |
Split 2 AGAINST, 2 ABSTAIN |
| BICARA THERAPEUTICS INC. | June 9, 2026 | To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal. Christopher Bowden, M.D. Director Elections |
Board | For | WITHHOLD 4 funds |
Split 1 FOR, 2 WITHHOLD |
| BILL HOLDINGS, INC. | December 11, 2025 | To approve, on an advisory basis, the compensation of our Named Executive Officers (Say-on-Pay). Say-on-Pay |
Board | For | AGAINST 4 funds |
Split 4 FOR, 2 ABSTAIN |
| BILL HOLDINGS, INC. | December 11, 2025 | To ratify the appointment of PricewaterhouseCoopers LLP as our Independent Registered Public Accounting Firm for the Fiscal Year ending June 30, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 4 FOR, 2 ABSTAIN |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Approval of the Amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan. Compensation |
Board | For | FOR 6 funds |
Split 2 FOR, 1 ABSTAIN |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Nominees: Arnold A. Pinkston Director Elections |
Board | For | FOR 6 funds |
Split 2 FOR, 1 ABSTAIN |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Nominees: Melinda Litherland Director Elections |
Board | For | FOR 6 funds |
Split 2 FOR, 1 ABSTAIN |
| BIO-RAD LABORATORIES, INC. | April 21, 2026 | Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors. Audit-related |
Board | For | FOR 6 funds |
Split 2 FOR, 1 ABSTAIN |
| BIO-TECHNE CORP | October 30, 2025 | Approve, on an advisory basis, the compensation of our executive officers. Say-on-Pay |
Board | For | AGAINST 11 funds |
Split 3 FOR, 3 AGAINST, 3 ABSTAIN |
| BIO-TECHNE CORP | October 30, 2025 | Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 2026 fiscal year. Audit-related |
Board | For | FOR 10 funds |
Split 6 FOR, 3 ABSTAIN |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. Compensation |
Board | For | AGAINST 2 funds |
Split 3 AGAINST, 1 ABSTAIN |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To hold a non-binding, advisory vote regarding executive compensation. Say-on-Pay |
Board | For | AGAINST 3 funds |
Split 3 AGAINST, 1 ABSTAIN |
| BIOCRYST PHARMACEUTICALS, INC. | June 11, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for 2026. Audit-related |
Board | For | FOR 2 funds |
Split 3 FOR, 1 ABSTAIN |
| BIOGEN INC. | June 9, 2026 | Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified. Maria C. Freire Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 6 ABSTAIN |
| BIOGEN INC. | June 9, 2026 | Say on Pay - To hold an advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 9 funds |
Split 5 FOR, 1 AGAINST, 6 ABSTAIN |
| BIOGEN INC. | June 9, 2026 | To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 5 FOR, 1 AGAINST, 6 ABSTAIN |
| BIOHAVEN LTD | April 28, 2026 | A non-binding advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
Split 4 FOR, 1 ABSTAIN |
| BIOHAVEN LTD | April 28, 2026 | Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. Heffernan Director Elections |
Board | For | AGAINST 2 funds |
Split 1 FOR, 2 AGAINST |
| BIOHAVEN LTD | April 28, 2026 | Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year 2026. Audit-related |
Board | For | FOR 2 funds |
Split 4 FOR, 1 ABSTAIN |
| BIOMARIN PHARMACEUTICAL INC. | June 2, 2026 | To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended. Compensation |
Board | For | AGAINST 10 funds |
Split 4 FOR, 1 ABSTAIN |
| BIOMARIN PHARMACEUTICAL INC. | June 2, 2026 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 11 funds |
Split 2 FOR, 2 AGAINST, 1 ABSTAIN |
| BIOMARIN PHARMACEUTICAL INC. | June 2, 2026 | To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 10 funds |
Split 4 FOR, 1 ABSTAIN |
| BIOMERIEUX SA | May 28, 2026 | APPROVE COMPENSATION OF ALEXANDRE MERIEUX, CHAIRMAN OF THE BOARD Say-on-Pay |
Board | For | FOR 4 funds |
Split 3 FOR, 1 AGAINST |
| BJ'S WHOLESALE CLUB HOLDINGS, INC. | June 18, 2026 | Approve, on an advisory (non-binding) basis, the compensation of the named executive officers of BJ's Wholesale Club Holdings, Inc. Say-on-Pay |
Board | For | FOR 10 funds |
Split 5 FOR, 3 ABSTAIN |
| BJ'S WHOLESALE CLUB HOLDINGS, INC. | June 18, 2026 | Ratify the appointment of PricewaterhouseCoopers LLP as BJ's Wholesale Club Holdings, Inc.'s independent registered public accounting firm for the fiscal year ending January 30, 2027. Audit-related |
Board | For | FOR 9 funds |
Split 5 FOR, 3 ABSTAIN |
| BLACK HILLS CORPORATION | April 29, 2026 | Advisory resolution to approve executive compensation. Say-on-Pay |
Board | For | FOR 3 funds |
Split 5 FOR, 1 ABSTAIN |
| BLACK HILLS CORPORATION | April 29, 2026 | Ratification of the appointment of Deloitte & Touche LLP to serve as Black Hills Corporation's independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 2 funds |
Split 5 FOR, 1 ABSTAIN |
| BLACKBAUD, INC. | June 10, 2026 | ADVISORY VOTE TO APPROVE THE 2025 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| BLACKBAUD, INC. | June 10, 2026 | APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE BLACKBAUD, INC. 2016 EQUITY AND INCENTIVE COMPENSATION PLAN. Compensation |
Board | For | FOR 6 funds |
Split 2 FOR, 1 ABSTAIN |
| BLACKBAUD, INC. | June 10, 2026 | RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026. Audit-related |
Board | For | FOR 6 funds |
Split 2 FOR, 1 ABSTAIN |
| BLACKLINE, INC. | May 7, 2026 | Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
Split 3 FOR, 1 AGAINST, 1 ABSTAIN |
| BLACKROCK, INC. | May 20, 2026 | Approval, in a non-binding advisory vote, of the compensation for named executive officers. Say-on-Pay |
Board | For | FOR 17 funds |
Split 5 FOR, 3 AGAINST, 1 ABSTAIN |
| BLACKROCK, INC. | May 20, 2026 | Ratification of the appointment of Deloitte LLP as BlackRock's independent registered public accounting firm for the fiscal year 2026. Audit-related |
Board | For | FOR 16 funds |
Split 8 FOR, 1 ABSTAIN |
| BLACKSTONE MORTGAGE TRUST, INC. | June 26, 2026 | Advisory Vote on Executive Compensation: To approve in a non-binding, advisory vote, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 1 fund |
Split 2 FOR, 1 ABSTAIN |
| BLOCK, INC. | June 16, 2026 | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | FOR 9 funds |
Split 7 FOR, 1 AGAINST, 2 ABSTAIN |
| BLOCK, INC. | June 16, 2026 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 8 FOR, 2 ABSTAIN |
| BLOOM ENERGY CORPORATION | May 21, 2026 | To approve an amendment to our Restated Certificate of Incorporation to remove outdated references to our Class B common stock. Capital Structure |
Board | For | FOR 6 funds |
Split 6 FOR, 3 ABSTAIN |
| BLOOM ENERGY CORPORATION | May 21, 2026 | To approve, on an advisory basis, the fiscal 2025 compensation of our named executive officers. Say-on-Pay |
Board | For | Split 2 FOR, 4 AGAINST |
Split 6 FOR, 3 ABSTAIN |
| BLOOM ENERGY CORPORATION | May 21, 2026 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal 2026. Audit-related |
Board | For | FOR 6 funds |
Split 6 FOR, 3 ABSTAIN |
| BLOOMIN' BRANDS, INC. | April 22, 2026 | Advisory Vote on Executive Compensation Say-on-Pay |
Board | For | AGAINST 8 funds |
Split 2 FOR, 1 ABSTAIN |
| BLOOMIN' BRANDS, INC. | April 22, 2026 | Election of Directors: Colleen Keating Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| BLOOMIN' BRANDS, INC. | April 22, 2026 | Election of Directors: David George Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| BLOOMIN' BRANDS, INC. | April 22, 2026 | Election of Directors: James Dinkins Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| BLOOMIN' BRANDS, INC. | April 22, 2026 | Election of Directors: John J. Mahoney Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| BLOOMIN' BRANDS, INC. | April 22, 2026 | Election of Directors: Julie Kunkel Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| BLOOMIN' BRANDS, INC. | April 22, 2026 | Election of Directors: Melanie Marein-Efron Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| BLOOMIN' BRANDS, INC. | April 22, 2026 | Election of Directors: Michael Spanos Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| BLOOMIN' BRANDS, INC. | April 22, 2026 | Election of Directors: R. Michael Mohan Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| BLOOMIN' BRANDS, INC. | April 22, 2026 | Election of Directors: Rohit Lal Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| BLOOMIN' BRANDS, INC. | April 22, 2026 | Ratification of Independent Registered Certified Public Accounting Firm Audit-related |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| BLUE BIRD CORPORATION | March 11, 2026 | To approve the Blue Bird Corporation Amended and Restated 2015 Omnibus Equity Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
Split 4 FOR, 1 AGAINST, 1 ABSTAIN |
| BLUE BIRD CORPORATION | March 11, 2026 | To ratify the appointment of the Company's independent registered public accounting firm for the 2026 fiscal year. Audit-related |
Board | For | FOR 8 funds |
Split 5 FOR, 1 ABSTAIN |
| BOISE CASCADE COMPANY | April 30, 2026 | Advisory vote approving the Company's executive compensation. Say-on-Pay |
Board | For | FOR 9 funds |
Split 3 FOR, 2 ABSTAIN |
| BOISE CASCADE COMPANY | April 30, 2026 | To ratify the appointment of KPMG as the Company's external auditors for the year ending December 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 3 FOR, 2 ABSTAIN |
| BOOKING HOLDINGS INC. | June 2, 2026 | Advisory vote to approve 2025 executive compensation. Say-on-Pay |
Board | For | FOR 19 funds |
Split 7 FOR, 1 AGAINST, 7 ABSTAIN |
| BOOKING HOLDINGS INC. | June 2, 2026 | Ratification of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 18 funds |
Split 7 FOR, 1 AGAINST, 7 ABSTAIN |
| BOOKING HOLDINGS INC. | June 2, 2026 | To elect eleven directors to hold office until the next annual meeting of stockholders and until their respective successors are elected and qualified. Glenn D. Fogel Director Elections |
Board | For | FOR 18 funds |
Split 6 FOR, 7 ABSTAIN |
| BOOT BARN HOLDINGS, INC. | August 27, 2025 | Election of Directors: Anne MacDonald Director Elections |
Board | For | FOR 5 funds |
Split 4 FOR, 2 WITHHOLD |
| BOOT BARN HOLDINGS, INC. | August 27, 2025 | Election of Directors: Brad Weston Director Elections |
Board | For | FOR 5 funds |
Split 4 FOR, 2 WITHHOLD |
| BOOT BARN HOLDINGS, INC. | August 27, 2025 | Election of Directors: Brenda I. Morris Director Elections |
Board | For | FOR 5 funds |
Split 4 FOR, 2 WITHHOLD |
| BOOT BARN HOLDINGS, INC. | August 27, 2025 | Election of Directors: Chris Bruzzo Director Elections |
Board | For | FOR 5 funds |
Split 4 FOR, 2 WITHHOLD |
| BOOT BARN HOLDINGS, INC. | August 27, 2025 | Election of Directors: Eddie Burt Director Elections |
Board | For | FOR 5 funds |
Split 4 FOR, 2 WITHHOLD |
| BOOT BARN HOLDINGS, INC. | August 27, 2025 | Election of Directors: John Hazen Director Elections |
Board | For | FOR 5 funds |
Split 4 FOR, 2 WITHHOLD |
| BOOT BARN HOLDINGS, INC. | August 27, 2025 | Election of Directors: Lisa G. Laube Director Elections |
Board | For | FOR 5 funds |
Split 4 FOR, 2 WITHHOLD |
| BOOT BARN HOLDINGS, INC. | August 27, 2025 | Election of Directors: Peter Starrett Director Elections |
Board | For | FOR 5 funds |
Split 4 FOR, 2 WITHHOLD |
| BOOT BARN HOLDINGS, INC. | August 27, 2025 | Ratification of Deloitte & Touche LLP as the independent auditor for the fiscal year ending March 28, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 4 FOR, 2 ABSTAIN |
| BOOT BARN HOLDINGS, INC. | August 27, 2025 | To vote on a non-binding advisory resolution to approve the compensation paid to named executive officers for fiscal 2025 ("say-on-pay"). Say-on-Pay |
Board | For | AGAINST 6 funds |
Split 4 FOR, 2 ABSTAIN |
| BOOZ ALLEN HAMILTON HOLDING CORPORATION | July 23, 2025 | Advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
Split 4 FOR, 1 ABSTAIN |
| BOOZ ALLEN HAMILTON HOLDING CORPORATION | July 23, 2025 | Ratification of the appointment of Ernst & Young LLP as the Company's registered independent public accountants for fiscal year 2026. Audit-related |
Board | For | FOR 8 funds |
Split 4 FOR, 1 ABSTAIN |
| BORGWARNER INC. | April 29, 2026 | Approve the Amended and Restated BorgWarner Inc. 2023 Stock Incentive Plan. Compensation |
Board | For | FOR 18 funds |
Split 5 FOR, 6 ABSTAIN |
| BORGWARNER INC. | April 29, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 19 funds |
Split 5 FOR, 6 ABSTAIN |
| BORGWARNER INC. | April 29, 2026 | Ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for 2026. Audit-related |
Board | For | FOR 18 funds |
Split 5 FOR, 6 ABSTAIN |
| BOSTON SCIENTIFIC CORPORATION | April 30, 2026 | To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance. Compensation |
Board | For | FOR 8 funds |
Split 8 FOR, 7 AGAINST |
| BOSTON SCIENTIFIC CORPORATION | April 30, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
Split 7 FOR, 1 AGAINST, 7 ABSTAIN |
| BOSTON SCIENTIFIC CORPORATION | April 30, 2026 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year. Audit-related |
Board | For | FOR 8 funds |
Split 7 FOR, 1 AGAINST, 7 ABSTAIN |
| BOWHEAD SPECIALTY HOLDINGS INC | April 30, 2026 | Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| BOX, INC. | June 25, 2026 | To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan to increase the number of shares reserved for issuance by 7,200,000 shares. Compensation |
Board | For | AGAINST 3 funds |
Split 1 FOR, 2 AGAINST, 2 ABSTAIN |
| BOX, INC. | June 25, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
Split 3 FOR, 2 ABSTAIN |
| BOX, INC. | June 25, 2026 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2027. Audit-related |
Board | For | FOR 3 funds |
Split 3 FOR, 2 ABSTAIN |
| BOYD GAMING CORPORATION | May 7, 2026 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 13 funds |
Split 4 FOR, 1 ABSTAIN |
| BOYD GAMING CORPORATION | May 7, 2026 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 12 funds |
Split 4 FOR, 1 ABSTAIN |
| BRAZE, INC. | June 30, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
Split 2 AGAINST, 1 ABSTAIN |
| BRAZE, INC. | June 30, 2026 | To ratify the selection by the audit committee of our board of directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2027. Audit-related |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| BREAD FINANCIAL HOLDINGS, INC. | May 19, 2026 | ADVISORY VOTE ON EXECUTIVE COMPENSATION Say-on-Pay |
Board | For | AGAINST 9 funds |
Split 3 FOR, 1 ABSTAIN |
| BREAD FINANCIAL HOLDINGS, INC. | May 19, 2026 | APPROVAL OF THE 2026 EMPLOYEE STOCK PURCHASE PLAN Compensation |
Board | For | FOR 8 funds |
Split 3 FOR, 1 AGAINST |
| BREAD FINANCIAL HOLDINGS, INC. | May 19, 2026 | RATIFICATION OF THE SELECTION OF DELOITTE & TOUCHE LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR 2026 Audit-related |
Board | For | FOR 8 funds |
Split 3 FOR, 1 ABSTAIN |
| BRENNTAG SE | May 20, 2026 | APPROVE REMUNERATION POLICY Say-on-Pay |
Board | For | AGAINST 4 funds |
Split 1 FOR, 2 AGAINST |
| BRENNTAG SE | May 20, 2026 | APPROVE REMUNERATION REPORT Say-on-Pay |
Board | For | AGAINST 4 funds |
Split 1 FOR, 2 AGAINST |
| BRIDGEBIO PHARMA, INC. | June 22, 2026 | To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares. Compensation |
Board | For | AGAINST 8 funds |
Split 4 FOR, 2 AGAINST, 3 ABSTAIN |
| BRIDGEBIO PHARMA, INC. | June 22, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 9 funds |
Split 6 FOR, 3 ABSTAIN |
| BRIDGEBIO PHARMA, INC. | June 22, 2026 | To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 6 FOR, 3 ABSTAIN |
| BRIGHTHOUSE FINANCIAL, INC. | February 12, 2026 | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Brighthouse Financial, Inc.'s named executive officers that is based on or otherwise relates to the Merger; and Say-on-Pay |
Board | For | AGAINST 9 funds |
Split 3 FOR, 1 ABSTAIN |
| BRIGHTHOUSE FINANCIAL, INC. | June 2, 2026 | Advisory vote to approve the compensation paid to Brighthouse Financial's Named Executive Officers Say-on-Pay |
Board | For | FOR 10 funds |
Split 3 FOR, 1 ABSTAIN |
| BRIGHTHOUSE FINANCIAL, INC. | June 2, 2026 | Election of nine (9) Directors each to serve a one-year term ending at the 2027 Annual Meeting of Stockholders C. Edward ("Chuck") Chaplin Director Elections |
Board | For | FOR 9 funds |
Split 3 FOR, 1 ABSTAIN |
| BRIGHTHOUSE FINANCIAL, INC. | June 2, 2026 | Ratification of the appointment of Deloitte & Touche LLP as Brighthouse Financial's independent registered public accounting firm for fiscal year 2026 Audit-related |
Board | For | FOR 9 funds |
Split 3 FOR, 1 ABSTAIN |
| BRIGHTSPRING HEALTH SERVICES, INC. | May 21, 2026 | Advisory vote on executive compensation Say-on-Pay |
Board | For | AGAINST 4 funds |
Split 5 FOR, 3 ABSTAIN |
| BRIGHTSPRING HEALTH SERVICES, INC. | May 21, 2026 | Ratification of the appointment of KPMG LLP as the independent accounting firm for the year ending December 31, 2026 Audit-related |
Board | For | FOR 3 funds |
Split 4 FOR, 3 ABSTAIN |
← Previous Page 14 of 100 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.